A Double-Blind, Randomized, Placebo Controlled, Crossover Study to Assess the Safety and Efficacy of Botulinum Toxin A Injections as a Preventative Measure for Herpes Labialis
Latest Information Update: 23 Dec 2020
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Herpes labialis
- Focus Therapeutic Use
- 24 Nov 2020 Status changed from completed to discontinued.
- 11 Feb 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 28 Mar 2014 According to ClinicalTrials.gov record planned end date changed from 1 May 2013 to 1 Jun 2014.